These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 22172720)

  • 1. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
    Damsky WE; Curley DP; Santhanakrishnan M; Rosenbaum LE; Platt JT; Gould Rothberg BE; Taketo MM; Dankort D; Rimm DL; McMahon M; Bosenberg M
    Cancer Cell; 2011 Dec; 20(6):741-54. PubMed ID: 22172720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
    Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA
    Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
    Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
    Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
    Yang H; Kircher DA; Kim KH; Grossmann AH; VanBrocklin MW; Holmen SL; Robinson JP
    Oncogene; 2017 Jul; 36(27):3842-3851. PubMed ID: 28263969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
    Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
    Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.
    Conde-Perez A; Gros G; Longvert C; Pedersen M; Petit V; Aktary Z; Viros A; Gesbert F; Delmas V; Rambow F; Bastian BC; Campbell AD; Colombo S; Puig I; Bellacosa A; Sansom O; Marais R; Van Kempen LC; Larue L
    Nat Commun; 2015 Aug; 6():8093. PubMed ID: 26307673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.
    Nogueira C; Kim KH; Sung H; Paraiso KH; Dannenberg JH; Bosenberg M; Chin L; Kim M
    Oncogene; 2010 Nov; 29(47):6222-32. PubMed ID: 20711233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
    Zingg D; Debbache J; Peña-Hernández R; Antunes AT; Schaefer SM; Cheng PF; Zimmerli D; Haeusel J; Calçada RR; Tuncer E; Zhang Y; Bossart R; Wong KK; Basler K; Dummer R; Santoro R; Levesque MP; Sommer L
    Cancer Cell; 2018 Jul; 34(1):69-84.e14. PubMed ID: 30008323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of MAPK signaling in BRAF-activated PTEN-deficient melanoma by blocking β-catenin signaling in cancer-associated fibroblasts.
    Zhou L; Yang K; Dunaway S; Abdel-Malek Z; Andl T; Kadekaro AL; Zhang Y
    Pigment Cell Melanoma Res; 2018 Mar; 31(2):297-307. PubMed ID: 29045061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.
    Gopal YN; Deng W; Woodman SE; Komurov K; Ram P; Smith PD; Davies MA
    Cancer Res; 2010 Nov; 70(21):8736-47. PubMed ID: 20959481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
    Chien AJ; Moore EC; Lonsdorf AS; Kulikauskas RM; Rothberg BG; Berger AJ; Major MB; Hwang ST; Rimm DL; Moon RT
    Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1193-8. PubMed ID: 19144919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
    Yoo JH; Brady SW; Acosta-Alvarez L; Rogers A; Peng J; Sorensen LK; Wolff RK; Mleynek T; Shin D; Rich CP; Kircher DA; Bild A; Odelberg SJ; Li DY; Holmen SL; Grossmann AH
    Cancer Res; 2019 Jun; 79(11):2892-2908. PubMed ID: 31048499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
    Bagati A; Moparthy S; Fink EE; Bianchi-Smiraglia A; Yun DH; Kolesnikova M; Udartseva OO; Wolff DW; Roll MV; Lipchick BC; Han Z; Kozlova NI; Jowdy P; Berman AE; Box NF; Rodriguez C; Bshara W; Kandel ES; Soengas MS; Paragh G; Nikiforov MA
    Oncogene; 2019 May; 38(19):3585-3597. PubMed ID: 30664687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MC1R is a potent regulator of PTEN after UV exposure in melanocytes.
    Cao J; Wan L; Hacker E; Dai X; Lenna S; Jimenez-Cervantes C; Wang Y; Leslie NR; Xu GX; Widlund HR; Ryu B; Alani RM; Dutton-Regester K; Goding CR; Hayward NK; Wei W; Cui R
    Mol Cell; 2013 Aug; 51(4):409-22. PubMed ID: 23973372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
    Braun AD; Mengoni M; Bonifatius S; Tüting T; Gaffal E
    J Invest Dermatol; 2020 Jul; 140(7):1410-1417.e2. PubMed ID: 31972251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
    Marsh Durban V; Deuker MM; Bosenberg MW; Phillips W; McMahon M
    J Clin Invest; 2013 Dec; 123(12):5104-18. PubMed ID: 24200692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors.
    Leick KM; Pinczewski J; Mauldin IS; Young SJ; Deacon DH; Woods AN; Bosenberg MW; Engelhard VH; Slingluff CL
    Cancer Immunol Immunother; 2019 Jul; 68(7):1121-1132. PubMed ID: 31134297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT1 Activation Promotes Development of Melanoma Metastases.
    Cho JH; Robinson JP; Arave RA; Burnett WJ; Kircher DA; Chen G; Davies MA; Grossmann AH; VanBrocklin MW; McMahon M; Holmen SL
    Cell Rep; 2015 Nov; 13(5):898-905. PubMed ID: 26565903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.